Volume 67 Received 21 May 2011 | ||||||||||
| ||||||||||
aSchool of Environmental Science & Engineering, Chang'an University, Xi'an 710054, Shaanxi, People's Republic of China, and bCollege of Chemistry and Materials Science, Northwest University, Xi'an 710069, Shaanxi, People's Republic of China
Correspondence e-mail: northwindy@126.com
The title compound, C6H10N8S2, was prepared by the nucleophilic substitution reaction of 5-mercapto-1-methyltetrazole and dichloroethane. In the crystal, the molecule possesses an approximate non-crystallographic twofold symmetry axis. The crystal packing is stabilized by weak intermolecular C-H
N and
-
interactions [centroid-centroid distances = 3.448 (6), 3.5085 (5) and 3.4591 (2) Å]. The two five-membered rings form a dihedral angle of 1.9 (2)°.
For the synthesis and structures of closely related compounds, see: She et al. (2006
); Wei et al. (2011
). For the pharmacological activity of tetrazole-containing compounds, see: Gilchrist (1992
); Armour et al. (1996
); Upadhayaya et al. (2004
). For applications of tetrazole derivatives in coordination chemistry and as energetic materials, see: Zhao et al. (2008
); Wang et al. (2009
).
|
|
| ||||||||||||||||||||||
Data collection: SMART (Bruker, 2002
); cell refinement: SAINT (Bruker, 2002
); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: ORTEP-3 (Farrugia, 1997
); software used to prepare material for publication: SHELXL97.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: YK2010 ).
We gratefully acknowledge the National Science Foundation of China (No. 20873100) and the Natural Science Foundation of Shaanxi Province (No. FF10091).
Armour, D. R., Chung, K. M. L., Congreve, M., Evans, B., Guntrip, S., Hubbard, T., Kay, C., Middlemiss, D., Mordaunt, J. E., Pegg, N. A., Vinader, M. V., Ward, P. & Watson, S. P. (1996). Bioorg. Med. Chem. Lett. 6, 1015-1020.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Bruker (2002). SMART, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.
![[details]](../../../../../../j/graphics/details.gif)
Gilchrist, T. L. (1992). Heterocyclic Chemistry, 2nd ed., pp. 505-511. New York: John Wiley & Sons.
She, J.-B., Zhang, G.-F., Dou, Y.-L., Fan, X.-Z. & Li, J.-Z. (2006). Acta Cryst. E62, o402-o404.
![[details]](../../../../../../e/graphics/details.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Upadhayaya, R. S., Jain, S., Sinha, N., Kishore, N., Chandra, R. & Arora, S. K. (2004). Eur. J. Med. Chem. 39, 579-592.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Wang, W. T., Chen, S. P. & Gao, S. L. (2009). Eur. J. Inorg. Chem. 23, 3475-3480.
Wei, W., Xia, Z., Chen, S. & Gao, S. (2011). Acta Cryst. E67, o999.
![[details]](../../../../../../e/graphics/details.gif)
Zhao, H., Qu, Z. R., Ye, H. Y. & Xiong, R. G. (2008). Chem. Soc. Rev. 37, 84-100.
![[PubMed]](../../../../../../logos/pubmedborder.gif)